- S&P Affirms Rating on Valeant Pharma (VRX) Amid Weak Q3 Report, Cut Outlook -> Read this!
Streetinsider.com's Hot Lunchtime Reads 11/8: (DEPO) (VRX) (VIPS) (PGNX)
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Volatility and Volume movement
- Axsome Therapeutics (AXSM) Files $200M Mixed Securities Shelf
- Trading Radar for 12/5: GW Pharma (GWPH), KongZhong (KZ) Report